Literature DB >> 25893461

Sampling frequency of fetal heart rate impacts the ability to predict pH and BE at birth: a retrospective multi-cohort study.

Xuan Li1, Yawen Xu, Christophe Herry, L Daniel Durosier, Daniela Casati, Tamara Stampalija, Emeline Maisonneuve, Andrew J E Seely, Francois Audibert, Zarko Alfirevic, Enrico Ferrazzi, Xiaogang Wang, Martin G Frasch.   

Abstract

Fetal heart rate (FHR) sampling rate used on the bedside is equal or less than 4 Hz. Current FHR analysis methods fail to detect incipient fetal acidemia. In a fetal sheep model of human labour we showed that FHR sampling rates near 1000 Hz are needed to detect fetal acidemia. Trans-abdominal fetal ECG (t-a fECG) sampling FHR at 900 Hz combined with a complex signals bioinformatics approach showed promise in a human cohort. Here we validate this finding in a retrospective human cohort study by comparing the performance of the same bioinformatics approach to predict pH and BE at birth in the cohorts with FHR sampled either at 4 Hz or at 900 Hz.The 4 Hz FHR recording data sets consisted of the open access intrapartum CTG data base with n = 552 subjects used to develop the predictive model and another cohort of prospectively recruited n = 11 labouring women to then validate it. 900 Hz FHR data set comprised two prospectively recruited t-a fECG cohorts of n = 60 and n = 23 subjects. Recruitment criteria were similar across the cohorts. We have determined the goodness of fit (R(2)) and root mean square error (RMSE) as the performance indicators of the model on each cohort.The clinical characteristics of all cohorts were similar (gestational age 280   ±   8 d; gender 50% male; birth body weight 3.5   ±   0.5 kg; pH and BE at birth 7.25   ±   0.1 and  -5.7   ±   3.4 mmol L(  -  1), respectively; 1' and 5' Apgar scores at birth 8.5   ±   1.4 and 9.4   ±   0.6, respectively). The 4 Hz FHR cohort rendered-for pH and BE-R(2) = 0.26 and 0.2 and RMSE = 0.087 and 3.44, respectively. This could not be confirmed in the validation cohort for neither pH nor BE prediction. The 900 Hz FHR cohort rendered-for pH and BE-R(2) = 0.9 and 0.77 and RMSE = 0.03 and 1.70, respectively, and the pH prediction was validated.In our model, lower FHR sampling rate increased the predicted error range ~3-4 fold. We show that increasing FHR sampling rate to 900 Hz improves prediction of fetal pH and BE at birth. This should improve early identification of babies at risk of brain injury.

Entities:  

Mesh:

Year:  2015        PMID: 25893461     DOI: 10.1088/0967-3334/36/5/L1

Source DB:  PubMed          Journal:  Physiol Meas        ISSN: 0967-3334            Impact factor:   2.833


  6 in total

1.  Efficient Fetal-Maternal ECG Signal Separation from Two Channel Maternal Abdominal ECG via Diffusion-Based Channel Selection.

Authors:  Ruilin Li; Martin G Frasch; Hau-Tieng Wu
Journal:  Front Physiol       Date:  2017-05-16       Impact factor: 4.566

2.  Decreased neuroinflammation correlates to higher vagus nerve activity fluctuations in near-term ovine fetuses: a case for the afferent cholinergic anti-inflammatory pathway?

Authors:  M G Frasch; M Szynkaruk; A P Prout; K Nygard; M Cao; R Veldhuizen; R Hammond; B S Richardson
Journal:  J Neuroinflammation       Date:  2016-05-10       Impact factor: 8.322

3.  Commentary: Computerised interpretation of fetal heart rate during labour (INFANT): a randomised controlled trial.

Authors:  Martin G Frasch; Geraldine B Boylan; Hau-Tieng Wu; Declan Devane
Journal:  Front Physiol       Date:  2017-09-28       Impact factor: 4.566

4.  A Hybrid EMD-Kurtosis Method for Estimating Fetal Heart Rate from Continuous Doppler Signals.

Authors:  Haitham M Al-Angari; Yoshitaka Kimura; Leontios J Hadjileontiadis; Ahsan H Khandoker
Journal:  Front Physiol       Date:  2017-08-30       Impact factor: 4.566

5.  Editorial: Perinatology in the Era of Big Data and Nanoparticles.

Authors:  Martin G Frasch
Journal:  Front Pediatr       Date:  2015-11-05       Impact factor: 3.418

6.  Heart during acidosis: Etiology and early detection of cardiac dysfunction.

Authors:  Martin G Frasch; Dino A Giussani
Journal:  EClinicalMedicine       Date:  2021-07-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.